نتایج جستجو برای: tau hyperphosphorylation

تعداد نتایج: 21929  

Journal: :PLoS ONE 2007
Simon Melov Paul A. Adlard Karl Morten Felicity Johnson Tamara R. Golden Doug Hinerfeld Birgit Schilling Christine Mavros Colin L. Masters Irene Volitakis Qiao-Xin Li Katrina Laughton Alan Hubbard Robert A. Cherny Brad Gibson Ashley I. Bush

Age-related neurodegenerative disease has been mechanistically linked with mitochondrial dysfunction via damage from reactive oxygen species produced within the cell. We determined whether increased mitochondrial oxidative stress could modulate or regulate two of the key neurochemical hallmarks of Alzheimer's disease (AD): tau phosphorylation, and beta-amyloid deposition. Mice lacking superoxid...

2015
An Verheyen Annick Diels Joyce Dijkmans Tutu Oyelami Giulia Meneghello Liesbeth Mertens Sofie Versweyveld Marianne Borgers Arjan Buist Pieter Peeters Miroslav Cik Jesús Avila

Alzheimer's disease and frontotemporal dementia are amongst the most common forms of dementia characterized by the formation and deposition of abnormal TAU in the brain. In order to develop a translational human TAU aggregation model suitable for screening, we transduced TAU harboring the pro-aggregating P301L mutation into control hiPSC-derived neural progenitor cells followed by differentiati...

2014
Franck R. Petry Jérôme Pelletier Alexis Bretteville Françoise Morin Frédéric Calon Sébastien S. Hébert Robert A. Whittington Emmanuel Planel

Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimer's disease. The causes and consequences of tau hyperphosphorylation are routinely investigated in laboratory animals. Mice are the models of choice as they are easily amenable to transgenic technology; consequently, their tau phosphorylation levels are frequently monitored ...

Journal: :Neuroscience 2013
P K Kamat S Rai S Swarnkar R Shukla S Ali A K Najmi C Nath

Okadaic acid (OKA) is a potent inhibitor of protein phosphatases 1/2A (PP2A). Inhibition of PP2A leads to hyperphosphorylation of Tau protein. Hyperphosphorylated Tau protein is present in intraneuronal neurofibrillary tangles a characteristic feature of neuropathology of Alzheimer's disease. Intracerebroventricular (ICV) administration of OKA causes neurotoxicity, which is associated with incr...

2017
Matthew Barron Jane Gartlon Lee A. Dawson Peter J. Atkinson Marie-Christine Pardon

Alzheimer's disease (AD), the predominant form of dementia, is highly correlated with the abnormal hyperphosphorylation and aggregation of tau. Immune responses are key drivers of AD and how they contribute to tau pathology in human disease remains largely unknown. This review summarises current knowledge on the association between inflammatory processes and tau pathology. While, preclinical ev...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2010
Stylianos Kosmidis Sofia Grammenoudi Katerina Papanikolopoulou Efthimios M C Skoulakis

Tauopathies are a heterogeneous group of neurodegenerative dementias involving perturbations in the levels, phosphorylation, or mutations of the microtubule-binding protein Tau. The heterogeneous pathology in humans and model organisms suggests differential susceptibility of neuronal types to wild-type (WT) and mutant Tau. WT and mutant human Tau-encoding transgenes expressed pan-neuronally in ...

2015
Yan-Si Xiong Fang-Fang Liu Dan Liu He-Zhou Huang Na Wei Lu Tan Jian-Guo Chen Heng-Ye Man Cheng-Xin Gong Youming Lu Jian-Zhi Wang Ling-Qiang Zhu

The two estrogen receptors (ERs), ERα and ERβ, mediate the diverse biological functions of estradiol. Opposite effects of ERα and ERβ have been found in estrogen-induced cancer cell proliferation and differentiation as well as in memory-related tasks. However, whether these opposite effects are implicated in the pathogenesis of Alzheimer's disease (AD) remains unclear. Here, we find that ERα an...

2013
Sefika Ozcelik Graham Fraser Perrine Castets Véronique Schaeffer Zhiva Skachokova Karin Breu Florence Clavaguera Michael Sinnreich Ludwig Kappos Michel Goedert Markus Tolnay David Theo Winkler

Altered autophagy contributes to the pathogenesis of Alzheimer's disease and other tauopathies, for which curative treatment options are still lacking. We have recently shown that trehalose reduces tau pathology in a tauopathy mouse model by stimulation of autophagy. Here, we studied the effect of the autophagy inducing drug rapamycin on the progression of tau pathology in P301S mutant tau tran...

Journal: :Neuron 2003
Wendy Noble Vicki Olm Kazuyuki Takata Evelyn Casey O Mary Jordana Meyerson Kate Gaynor John LaFrancois Lili Wang Takayuki Kondo Peter Davies Mark Burns Veeranna Ralph Nixon Dennis Dickson Yasuji Matsuoka Michael Ahlijanian Lit-Fui Lau Karen Duff

Tau aggregation is a common feature of neurodegenerative diseases such as Alzheimer's disease, and hyperphosphorylation of tau has been implicated as a fundamental pathogenic mechanism in this process. To examine the impact of cdk5 in tau aggregation and tangle formation, we crossed transgenic mice overexpressing the cdk5 activator p25, with transgenic mice overexpressing mutant (P301L) human t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید